| Annette Vallejo, OTR/L | |
|
601 Horizon Pl, Grand Junction, CO 81506-1915 | |
| (970) 241-0772 | |
| Not Available |
| Full Name | Annette Vallejo |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 601 Horizon Pl, Grand Junction, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326619990 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT.0004312 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Annette Vallejo, OTR/L 1270 Pinyon Ave, Grand Junction, CO 81501-8524 Ph: (970) 314-3536 | Annette Vallejo, OTR/L 601 Horizon Pl, Grand Junction, CO 81506-1915 Ph: (970) 241-0772 |
News Archive
Wanting to replace the medical equipment for taking X-rays, the Mexican Society of Radiology (CMR) created a system of digital x-ray imaging, which replaces the traditional plaque by a solid detector, which delivers results in five seconds. Analog equipment take six minutes to develop the traditional film.
There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.
Something - or some things - in the blood of young mice has the ability to restore mental capabilities in old mice, a new study by Stanford University School of Medicine investigators has found.
Genentech, a member of the Roche Group, today announced that the SUMMACTA study met its primary endpoint, showing comparable efficacy (non-inferiority) of the subcutaneous (SC) formulation of ACTEMRA (tocilizumab) 162mg weekly compared to 8 mg/kg ACTEMRA intravenous (IV) formulation every four weeks.
› Verified 4 days ago
Christina L Moore, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 3150 N 12th St, Grand Junction, CO 81506 Phone: 970-241-5856 Fax: 970-241-8599 | |
Ms. Dianne Jean Cataldi, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3017 Sequel Way, Grand Junction, CO 81504 Phone: 860-460-6026 | |
Mrs. Gena Avey Tadych, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2121 North Ave, Grand Junction, CO 81501 Phone: 970-244-1335 Fax: 970-244-1323 | |
Mrs. Juliann Hanson, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 2373 G Rd Ste 100, Grand Junction, CO 81505 Phone: 970-245-0484 | |
Michael Anders, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 2505 Foresight Cir Unit C2, Grand Junction, CO 81505 Phone: 970-216-9398 | |
Talley Halvorson, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 627 25 1/2 Rd, Grand Junction, CO 81505 Phone: 970-242-3535 | |
Mrs. Lisa Elaine Gustin, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2115 Grand Ave, Grand Junction, CO 81501 Phone: 970-254-4872 |